AIDS 2010

XVIII International AIDS Conference

Vienna 18-23 July 2010

aidsmap.com: official provider of online news coverage - AIDS 2010

News from the conference

Three tactics to stem the tide of criminal prosecutions

Scientists, lawyers and advocates have been able to reduce unwarranted prosecutions of HIV exposure and transmission in three European jurisdictions by employing three distinct approaches, Robert James

Published
29 July 2010
By
Roger Pebody
Less than 10% of East European prevention spending is for vulnerable groups

In the countries of Eastern Europe and Central Asia, 89% of national government funding for HIV prevention goes on programmes for the general population, although most countries’

Published
28 July 2010
By
Roger Pebody
New studies strengthen evidence that drug addiction is a disease of the brain; substitution therapy necessary

Two scientific lectures presented at the Eighteenth International AIDS Conference in Vienna last week, demonstrated that drug use in and of itself is linked to increased

Published
27 July 2010
By
Mara Kardas-Nelson
Evidence-based treatment of drug users needed to strengthen human rights, stem drug use, and halt the HIV epidemic

Drug policies based on ideology rather than science are fueling human rights abuses of drug users, according to a panel of experts speaking at last week’s Eighteenth

Published
27 July 2010
By
Mara Kardas-Nelson
'The business of public health': new research on financing of HIV programmes

At the International AIDS Conference in Vienna, a session on the financing of HIV programmes yielded important results about the long-term costs and health impacts of

Published
27 July 2010
By
Rebecca Hodes
Mass testing campaign unjustified if people fail to receive treatment, activist argues

South Africa’s campaign to test 15 million people for HIV in one year risks being implemented in a way that undermines people’s human rights, the activist Mark

Published
27 July 2010
By
Roger Pebody
Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

Combination antiretroviral regimens containing atazanavir (Reyataz) plus drugs from two newer classes – the integrase inhibitor raltegravir (Isentress) and the CCR5 antagonist maraviroc (Celsentri) – demonstrated promising anti-HIV activity,

Published
26 July 2010
By
Liz Highleyman
Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

People who had a low CD4 cell count in the past remain at greater risk for HIV-related neurocognitive impairment even after they start antiretroviral therapy and their

Published
26 July 2010
By
Liz Highleyman
Prevention strategies need to target both early and chronic HIV infection

An analysis of transmission patterns in Lilongwe, Malawi shows that even if a highly effective HIV prevention intervention could reach 75% of people in chronic infection, it

Published
26 July 2010
By
Roger Pebody
Estudo CASCADE: benefícios do tratamento anti-retroviral evidentes abaixo das 500 células CD4 e incertos acima deste valor

Vá directamente para: Referência Mais informação De acordo com o estudo CASCADE, cujos resultados foram apresentados na 18ª Conferência Mundial da SIDA, em Viena, no final de Julho

Published
23 July 2010
By
Liz Highleyman
← Prev12345...7Next →

News and tweets

NAM’s team of writers will be attending conference sessions and reporting on findings throughout the conference. Their news reports will be published here every day, with links to abstracts and webcasts where available.

You can also follow NAM's Senior Editor, Keith Alcorn, on Twitter: http://twitter.com/keithalcorn

More coverage of the conference

Two other official partners of the conference will be providing coverage and analysis online and we will link to their coverage in our news and bulletins, so you can have the fullest picture of the conference.

Clinical Care Options (CCO), will be providing audio highlights, capsule summaries and downloadable slidesets, while the Kaiser Family Foundation will be providing webcasting from conference sessions.